Angina pectoris is the clinical chest pain syndrome that occurs when the heart muscle receives insufficient oxygen to meet its metabolic needs. This imbalance creates myocardial ischemia. The heart relies almost entirely on aerobic metabolism, meaning it requires a steady, uninterrupted supply of oxygen delivered via the coronary arteries.
Myocardial oxygen demand is primarily driven by four key factors, often remembered as the major determinants of cardiac workload:
When coronary arteries are narrowed by atherosclerosis, they cannot dilate to supply extra blood during times of exertion or stress. Antianginal drugs work by either increasing oxygen supply through coronary vasodilation or decreasing oxygen demand by reducing heart rate, preload, contractility, or afterload.
Nitrates, such as nitroglycerin and isosorbide dinitrate, are foundational drugs for relieving acute anginal attacks and preventing episodes. They act as prodrugs that release nitric oxide inside vascular smooth muscle. Nitric oxide activates guanylyl cyclase, increasing cyclic GMP and causing a cascade that dephosphorylates myosin light chains, leading to smooth muscle relaxation.
Venodilation is the primary therapeutic effect of standard doses. By relaxing large veins, nitrates pool blood in the periphery, which substantially reduces venous return or preload. Lower preload means smaller ventricular volume and lower wall tension, drastically cutting myocardial oxygen demand. At higher doses, they also dilate large coronary arteries, improving blood flow to ischemic areas of the heart.
Administration routes vary based on clinical goals:
Beta-blockers are first-line prophylactic therapy for chronic stable angina. They competitive-inhibit catecholamines like epinephrine and norepinephrine at beta-adrenergic receptors. By blocking beta-1 receptors in the heart, these agents reduce heart rate (negative chronotropy) and decrease myocardial contractility (negative inotropy).
Lowering the heart rate extends diastole, which is the exact window when the coronary arteries fill with blood. This dual action—decreasing overall oxygen demand while simultaneously improving coronary perfusion time—makes beta-blockers exceptionally effective at preventing anginal attacks during exercise or emotional stress.
Abrupt cessation of beta-blockers is dangerous. Stopping them suddenly triggers a rebound sympathetic hypersensitivity, which can precipitate severe unstable angina, myocardial infarction, or sudden cardiac arrhythmias. Nurses must reinforce that these medications must always be tapered gradually under medical supervision.
Calcium channel blockers (CCBs) inhibit the transmembrane influx of calcium ions into cardiac muscle cells and smooth muscle cells of coronary and systemic arteries. Calcium is strictly required for muscle contraction; restricting its entry leads to smooth muscle relaxation and vasodilation.
CCBs are broadly divided into two major structural and functional groups:
These drugs are particularly useful for variant or vasospastic angina, where coronary artery spasms suddenly restrict blood supply regardless of physical activity. They are also standard alternatives when patients have contraindications to beta-blockers, such as severe asthma or chronic obstructive pulmonary disease.
When traditional first-line agents like beta-blockers, calcium channel blockers, and long-acting nitrates fail to control symptoms fully, adjuvant medications are introduced.
These drugs offer therapeutic flexibility for patients with persistent, debilitating angina who cannot tolerate higher doses of traditional medications due to low baseline blood pressure or bradycardia.
Comprehensive nursing assessment is vital for safe antianginal therapy. Before administering any cardiovascular medication, the nurse must evaluate baseline hemodynamic parameters. Blood pressure and heart rate must be checked to screen for baseline hypotension or bradycardia, which would make agents like beta-blockers or non-dihydropyridine calcium channel blockers unsafe.
When a patient experiences an acute anginal attack, the nurse must systematically assess the pain characteristics using standard clinical markers, tracking location, radiation, severity, and associated symptoms like diaphoresis, nausea, or shortness of breath.
Continuous monitoring during therapy involves watching for drug-specific adverse effects. For instance, dihydropyridine calcium channel blockers frequently cause peripheral edema due to preferential arteriolar dilation, which can be mistaken for worsening heart failure. Regular review of electrocardiograms is also necessary to detect emerging conduction blocks or ischemic changes.
Effective patient education ensures adherence and prevents life-threatening administration errors. Patients prescribed sublingual nitroglycerin must understand proper storage and usage. The tablets degrade rapidly when exposed to heat, moisture, and light, so they must be kept in their original dark glass container and replaced every three to six months.
Instructions for taking sublingual nitroglycerin during an acute attack must be clear:
Patients must also be warned about severe drug interactions. Combining nitrates with phosphodiesterase type-5 inhibitors (such as sildenafil for erectile dysfunction) causes a catastrophic, treatment-resistant drop in blood pressure due to cumulative vasodilation.